Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03555617 · ClinicalTrials.gov registry record · Phase 1
Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study
A Phase 1 study, sponsored by Theravance Biopharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT03555617 is a Phase 1 study that has completed, run by Theravance Biopharma. The registered enrollment target is 36 participants.
The verdict
NCT03555617, a Phase 1 study, has completed, sponsored by Theravance Biopharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a Phase 1, open-label, 2-cohort, food-effect, DDI, and formulation bridging study.
Interventions
- DRUG Itraconazole
- DRUG TD-1473
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2018-06-13 |
| Est. Completion | 2018-07-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03555617
The ClinicalTrials.gov registry entry for NCT03555617 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theravance Biopharma, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Itraconazole is the first listed.
NCT03555617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03555617 about?
NCT03555617 is a clinical study titled "Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study". This is a Phase 1, open-label, 2-cohort, food-effect, DDI, and formulation bridging study.
What is the current status of trial NCT03555617?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2018-06-13. Estimated completion is 2018-07-15.
What interventions are being tested in trial NCT03555617?
The interventions under investigation include: Itraconazole (DRUG), TD-1473 (DRUG).
Who is sponsoring clinical trial NCT03555617?
This trial is sponsored by Theravance Biopharma, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.